We are live on
!
Find out more
GC
Gratry & Company Portfolio holdings
AUM
$72.2M
1-Year Est. Return
19.87%
This Fund
S&P 500
This Quarter
Est. Return
+3.03%
1 Year Est. Return
+19.87%
3 Year Est. Return
+44.17%
5 Year Est. Return
+89.51%
10 Year Est. Return
–
AUM
$278M
AUM Growth
-$27.6M
(-9%)
Cap. Flow
-$26.4M
Cap. Flow
% of AUM
-9.52%
Top 10 Holdings %
Top 10 Hldgs %
34.89%
Holding
73
New
4
Increased
18
Reduced
38
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pentair
PNR
|
+$7.32M |
| 2 |
AGN
Allergan plc
AGN
|
+$6.81M |
| 3 |
NBIS
Nebius Group N.V.
NBIS
|
+$4.72M |
| 4 |
HIT
HITACHI LTD ADR (10COM)NEW
HIT
|
+$3.49M |
| 5 |
Melco Resorts & Entertainment
MLCO
|
+$3.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ORIX
IX
|
+$8.45M |
| 2 |
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
|
+$8.42M |
| 3 |
ESV
Ensco Rowan plc
ESV
|
+$6.83M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
+$6.78M |
| 5 |
BRG
BG GROUP PLC ADS(RP 5 ORD SHS)
BRG
|
+$6.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.94% |
| 2 | Industrials | 13.6% |
| 3 | Financials | 11.96% |
| 4 | Consumer Discretionary | 9.06% |
| 5 | Technology | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
JPMorgan Chase
JPM
$916B
| $347K | 0.12% |
5,715
| – | – |
|
52
Stryker
SYK
$135B
| $319K | 0.11% |
3,913
-562
| -13% | -$44.7K |
|
53
3M
MMM
$91.8B
| $271K | 0.1% |
2,386
-203
| -8% | -$22.6K |
|
|
BRFS
54
DELISTED
BRF SA
BRFS
| – | – |
-14,925
| Closed | -$311K |
|
55
HSBC
HSBC
$352B
| – | – |
-114,642
| Closed | -$5.45M |
|
|
56
ORIX
IX
$42.7B
| – | – |
-474,125
| Closed | -$8.45M |
|
57
Nomura Holdings
NMR
$28.3B
| – | – |
-11,590
| Closed | -$90K |
|
|
BSMX
58
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| – | – |
-196,871
| Closed | -$2.69M |
|
|
KSU
59
DELISTED
Kansas City Southern
KSU
| – | – |
-5,295
| Closed | -$656K |
|
|
SI
60
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| – | – |
-60,799
| Closed | -$8.42M |
|
|
ESV
61
DELISTED
Ensco Rowan plc
ESV
| – | – |
-29,846
| Closed | -$6.83M |
|
|
BRG
62
DELISTED
BG GROUP PLC ADS(RP 5 ORD SHS)
BRG
| – | – |
-305,680
| Closed | -$6.63M |
|
|
CEO
63
DELISTED
CNOOC Limited
CEO
| – | – |
-32,236
| Closed | -$6.05M |
|
Similar funds
T
DCM
XS
BSCP
SCM
FMA
MSTVIM
LA
Gratry & Company's Q1 2014 Portfolio in Review
As of Q1 2014, Gratry & Company held 73 positions worth $278M, down 9% from $305M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Gratry & Company withdrew a net $26.4M in Q1 2014, closing 10 positions and reducing 38 holdings. Its most notable exit was ORIX, an estimated $8.45M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.
Against the trend, Gratry & Company opened a new position in Pentair worth $7.47M.
- Gratry & Company's largest Q1 2014 buy was Pentair: 140,152 shares worth $7.47M.
- Gratry & Company added most to Nebius Group N.V. in Q1 2014, an estimated $4.72M increase.
- Gratry & Company's biggest Q1 2014 reduction was Jazz Pharmaceuticals, cutting an estimated $6.78M.
- Gratry & Company fully exited ORIX in Q1 2014, selling an estimated $8.45M.
- Gratry & Company's ten largest holdings make up 35% of its $278M portfolio in Q1 2014.
- Gratry & Company opened 4 new positions and closed 10 in Q1 2014.
- Gratry & Company's portfolio value fell 9% quarter-over-quarter to $278M.
Based on Gratry & Company's 13F filing for Q1 2014, filed 20 May 2014.